Cooper Profit Margin 2012-2026 | COO

Current and historical gross margin, operating margin and net profit margin for Cooper (COO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Cooper net profit margin as of July 31, 2026 is 13.46%.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $10.130B $4.092B
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $104.880B 22.04
Cardinal Health (CAH) United States $54.109B 20.66
Becton Dickinson (BDX) United States $51.228B 14.30
West Pharmaceutical Services (WST) United States $25.687B 42.94
Straumann Holding AG (SAUHY) Switzerland $18.592B 0.00
Align Technology (ALGN) United States $10.528B 16.28
Henry Schein (HSIC) United States $9.754B 16.48
Merit Medical Systems (MMSI) United States $5.146B 23.48
DENTSPLY SIRONA (XRAY) United States $1.960B 6.87
CONMED (CNMD) United States $1.406B 9.82
STAAR Surgical (STAA) United States $1.125B 35.07
Pro-Dex (PDEX) United States $0.214B 19.97
Lifevantage (LFVN) United States $0.077B 11.04